TRCT
FRLN

Tower Research Capital (TRC)’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Tower Research Capital (TRC)’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13
Closed -$1K – 6732
2021
Q3 		$1K Buy
+13
New +$924 ﹤0.01% 5578

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Tower Research Capital (TRC)'s FRLN Position: Q4 2021 in Review

Tower Research Capital (TRC) sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2021, closing a stake of 13 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in FRLN in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 18 funds tracked by Wall St. Rank hold FRLN as of Q4 2021.

  • Tower Research Capital (TRC) reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 13 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2021, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2021 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $1K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.